Clinical Trial Update: Reduction of MTX Levels After Glucarpidase Treatment in DLBCL Patients at Risk of CNS [Phase 2]

View source ↗

Summary

This Phase 2 trial investigates reduction of methotrexate levels after glucarpidase treatment in Diffuse Large B-Cell Lymphoma patients at risk of CNS involveme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Glucarpidase (glucarpidase)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Fundacion CRIS de Investigación para Vencer el Cáncer | Conditions: Diffuse Large B-Cell Lymphoma, Drug Toxicity | Phase 2 | Status: TERMINATED